Citrate Plasma Levels in Patients Under Regional Anticoagulation in Continuous Venovenous Hemofiltration

American Journal of Kidney Diseases

Volumn 48, Issue 5, 2006, Pages 806-811

  Hetzel, Gerd R ^a   Taskaya, Gediz ^a   Sucker, Christoph ^a   Hennersdorf, Marcus ^a   Grabensee, Bernd ^a   Schmitz, Michael ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

anticoagulation; Citrate; continuous venovenous hemofiltration (CVVH); hemofiltration

Indexed keywords

CALCIUM ION; CITRIC ACID;

ADULT; AGED; ANION GAP; ANTICOAGULANT THERAPY; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; FEMALE; HUMAN; MALE; MATHEMATICAL COMPUTING; PH MEASUREMENT; STEADY STATE;

ADULT; AGED; ANTICOAGULANTS; CALCIUM; CITRIC ACID; CRITICAL ILLNESS; FEMALE; HEMODIALYSIS SOLUTIONS; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 33751010475     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2006.07.016     Document Type: Article

References (20)

1. Nuthall G., Skippen P., Daoust C., Al-Jofan F., and Seear M. Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy. Crit Care Med 30 (2002) 900-903
2. Calatzis A., Toepfer M., Schramm W., Spannagl M., and Schiffl H. Citrate anticoagulation for extracorporeal circuits: Effects on whole blood coagulation activation and clot formation. Nephron 89 (2001) 233-236
3. Kramer L., Bauer E., Joukhadar C., et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 31 (2003) 2450-2455
4. Wexler I.B., Pincus J.B., Natelson S., et al. Fate of citrate in erythroblastic infants treated with exchange transfusion. J Clin Invest 28 (1949) 474-481
5. Mehta R.L., McDonald B.R., Aguilar M.M., and Ward D.M. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38 (1990) 976-981
6. Diaz J., Acosta F., Parrilla P., et al. Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem 28 (1995) 315-317
7. Nowak M.A., and Campbell T.E. Profound hypercalcemia in continuous veno-venous hemofiltration dialysis with trisodium citrate anticoagulation and hepatic failure. Clin Chem 43 (1997) 412-413
8. Meier-Kriesche H.U., Finkel K.W., Gitomer J.J., and DuBose T.D. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 33 (1999) 1-4
9. Meier-Kriesche H.U., Gitomer J., Finkel K., and DuBose T.D. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29 (2001) 748-752
10. Pannu N., and Gibney N. Metabolic parameters in 30 patients treated with CRRT using regional citrate anticoagulation. Blood Purif 20 (2002) 305-323
11. Schmitz M., Taskaya G., Plum J., Peters A., Grabensee B., and Hetzel G.R. Citrate as buffer and anticoagulant in continuous veno-venous hemofiltration (CVVH): Acid base stability and citrate levels. Nephrol Dial Transplant 20 suppl 5 (2005) S335-S336
12. Palsson R., and Niles J.L. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 55 (1999) 1991-1997
13. Morgera S., Haase M., Ruckert M., et al. Regional citrate anticoagulation in continuous hemodialysis-Acid-base and electrolyte balance at an increased dose of dialysis. Nephron Clin Pract 101 (2005) c211-c219
14. Finkel K.W., and Foringer J.R. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Ren Fail 27 (2005) 541-545
15. Bagshaw S.M., Laupland K.B., Boiteau P.J., and Godinez-Luna T. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy?. A prospective observational study in an adult regional critical care system. J Crit Care 20 (2005) 155-161
16. Oberbauer R., Fabrizii V., Druml W., and Mayer G. Acute acid-base disorder during plasma immunoadsorption treatment using citrate anticoagulation. Nephrol Dial Transplant 13 (1998) 1581-1582
17. De Vos J., and Hombrouckx R. Citrate anticoagulation and adverse events. Edtna Erca J 29 (2003) 112-113
18. Morgera S., Scholle C., Voss G., et al. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: Single-center experience. Nephron Clin Pract 97 (2004) c131-c136
19. Gong D., Ji D., Xu B., Xie H., Liu Y., and Li L. Regional citrate anticoagulation in critically ill patients during continuous blood purification. Chin Med J (Engl) 116 (2003) 360-363
20. Uchino S., Fealy N., Baldwin I., Morimatsu H., and Bellomo R. Continuous venovenous hemofiltration without anticoagulation. Asaio J 50 (2004) 76-80